Choosing between Recursion Pharmaceuticals (NASDAQ:RXRX) and Summit Therapeutics (NASDAQ:SMMT) requires weighing the broad potential of artificial intelligence against the specific clinical prospects ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

With almost the last kick of the game, the United States men's national team lost to Türkiye 2-2 in Los Angeles on Thursday. Christian Pulisic made his return to the pitch following a thigh injury as ...

Editor's note: Keep up with the USA-Turkey game with our live blog here. IRVINE, CA — For the U.S. men's national team, this is truly uncharted territory. Never before has the team entered its final ...

It's pandemonium in New York. The San Antonio Spurs opened a big lead early Wednesday and silenced a Madison Square Garden crowd for a second straight time in Game 4 of the NBA Finals. But a 29-point ...

A strong earthquake in the southern Gulf off Cuba was felt in parts of South Florida and the rest of the state on Monday. According to the U.S. Geological Survey, the 6.1 magnitude quake happened ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

Anthropic reveals that Claude now writes over 80% of its production code, with engineers shipping 8x more code per quarter than in 2024. The company’s new Anthropic Institute paper maps the path to ...

Anthropic said its powerful new AI model, Mythos, could be dangerous in the wrong hands. WSJ’s Nicole Nguyen explains why and shares some cybersecurity tips for the average tech user. Photo: Sean ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

As drug discovery moves from trial-and-error to digital simulation, choosing between Recursion Pharmaceuticals(NASDAQ:RXRX) and Schrödinger(NASDAQ:SDGR) depends on ...